U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

Today, the U.S. Food and Drug Administration is alerting patients of a safety concern regarding diabetes devices, such as continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing ...

US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices: Maryland Friday, February 7, 2025, 09:0 ...

Some patients with diabetes may be missing critical safety alerts on their phones, the FDA warned on Wednesday.

The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical safety alerts.

A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...

Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using ...

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...